Verve Therapeutics is based in Burlington, MA. It has raised $216M in total funding. Latest round: Series B.
Verve Therapeutics is based in Burlington, MA. Verve Therapeutics has raised $216M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Verve Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include ELI Casdin, Wellington Management, Brainchild, F Prime Capital, GV, OAK HC/FT and 11 others. 17 distinct backers are named across the disclosed rounds.
Round data for Verve Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Burlington and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026